{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:23:18Z","timestamp":1789543398955,"version":"build-2803163510"},"reference-count":125,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012513","name":"Biomedical Research Network Centre in Cardiovascular Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009664","name":"Spanish Society of Cardiology","doi-asserted-by":"publisher","award":["RLD_SEC2016"],"award-info":[{"award-number":["RLD_SEC2016"]}],"id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009664","name":"Spanish Society of Cardiology","doi-asserted-by":"publisher","award":["SECAINC-INV-ICC 23\/02"],"award-info":[{"award-number":["SECAINC-INV-ICC 23\/02"]}],"id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI24\/00114"],"award-info":[{"award-number":["PI24\/00114"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21\/01145"],"award-info":[{"award-number":["PI21\/01145"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017210","name":"Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017209","name":"Fundaci\u00f3n Instituto de Investigaci\u00f3n Sanitaria de Santiago de Compostela","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010769","name":"Axencia Galega de Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118439","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:51:36Z","timestamp":1754959896000},"page":"118439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Soluble guanylate cyclase stimulation improves cardiac function and mitochondrial activity in a rat model of early-stage heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"191","author":[{"given":"Xocas","family":"V\u00e1zquez-Abu\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-9581","authenticated-orcid":false,"given":"Sandra","family":"Mora\u00f1a-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3089-0684","authenticated-orcid":false,"given":"Alana","family":"Arag\u00f3n-Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3156-8862","authenticated-orcid":false,"given":"Karen","family":"Thomitzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garc\u00eda-Seara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7615-3079","authenticated-orcid":false,"given":"Susana B.","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Otero-Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1264-8256","authenticated-orcid":false,"given":"Pablo","family":"de la Fuente-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9091-7775","authenticated-orcid":false,"given":"Carlos","family":"Tilves-Bellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2858-7945","authenticated-orcid":false,"given":"Alexandre","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Pereira Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas N.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Sousa-Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Falc\u00e3o-Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Taraz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Rosell\u00f3-Llet\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Portol\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7154-1328","authenticated-orcid":false,"given":"Oreste","family":"Gualillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3739-5806","authenticated-orcid":false,"given":"Sandra","family":"Feij\u00f3o-Band\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Lago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118439_bib1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1124\/pharmrev.124.001060","article-title":"Nitric oxide signaling and regulation in the cardiovascular system: recent advances","volume":"76","author":"Carlstr\u00f6m","year":"2024","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.biopha.2025.118439_bib2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1152\/physrev.00015.2023","article-title":"Phosphodiesterase in heart and vessels: from physiology to diseases","volume":"104","author":"Fu","year":"2024","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.118439_bib3","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jacc.2020.08.031","article-title":"Targeting cyclic guanosine monophosphate to treat heart failure","volume":"76","author":"Emdin","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00395-018-0679-9","article-title":"cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway","volume":"113","author":"Park","year":"2018","journal-title":"Basic Res Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112894","article-title":"Development of vericiguat: the first soluble guanylate cyclase (sGC) stimulator launched for heart failure with reduced ejection fraction (HFrEF)","volume":"149","author":"Xia","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.118439_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/13543776.2021.1866538","article-title":"Soluble guanylate cyclase stimulators and their potential use: a patent review","volume":"31","author":"Sandner","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2025.118439_bib7","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1021\/acs.jmedchem.7b00449","article-title":"Discovery of the soluble guanylate cyclase stimulator vericiguat (BAY 1021189) for the treatment of chronic heart failure","volume":"60","author":"Follmann","year":"2017","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2025.118439_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008735","article-title":"Vericiguat improves aortic wave reflection parameters in a new preclinical model of hypertension","volume":"15","author":"Boden","year":"2022","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib9","doi-asserted-by":"crossref","unstructured":"S. Breitenstein, L. Roessig, P. Sandner, K.S. Lewis, Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure, in: 2016: pp. 225\u2013247. https:\/\/doi.org\/10.1007\/164_2016_100.","DOI":"10.1007\/164_2016_100"},{"key":"10.1016\/j.biopha.2025.118439_bib10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jchf.2023.12.005","article-title":"Recurrent hospitalizations and response to vericiguat in heart failure and reduced ejection fraction","volume":"12","author":"Mentz","year":"2024","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jchf.2022.12.014","article-title":"Ejection fraction, biomarkers, and outcomes and impact of vericiguat on outcomes across EF in Victoria","volume":"11","author":"Butler","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jchf.2023.06.020","article-title":"Age, sex, and outcomes in heart failure with reduced EF","volume":"11","author":"Lam","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib13","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jama.2020.15922","article-title":"Effect of vericiguat vs placebo on quality of life in patients with heart failure and preserved ejection fraction","volume":"324","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2025.118439_bib14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/eurheartj\/ehw593","article-title":"Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate cyclase stimulator in heArT failure patients with PRESERVED EF (SOCRATES-PRESERVED) study","volume":"38","author":"Pieske","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2025.118439_bib15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/cvr\/cvaa123","article-title":"Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase G\u03b1 oxidation","volume":"117","author":"Kolijn","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2025.118439_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.011792","article-title":"Proteomics identify clinical phenotypes and predict functional outcomes in heart failure with preserved ejection fraction: insights from VITALITY-HFpEF","volume":"17","author":"deFilippi","year":"2024","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jchf.2023.01.017","article-title":"Exploring ejection fraction range in heart failure clinical trials","volume":"11","author":"Konstam","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106931","article-title":"Modulation of the nitric oxide\/cGMP pathway in cardiac contraction and relaxation: potential role in heart failure treatment","volume":"196","author":"Mollace","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118439_bib19","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1001\/jama.2020.16641","article-title":"Effect of praliciguat on peak rate of oxygen consumption in patients with heart failure with preserved ejection fraction","volume":"324","author":"Udelson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2025.118439_bib20","article-title":"Differential sex-dependent susceptibility to diastolic dysfunction and arrhythmia in cardiomyocytes from obese diabetic heart failure with preserved ejection fraction model","author":"Mira Hernandez","year":"2024","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.biopha.2025.118439_bib21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/cvr\/cvae006","article-title":"Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction","volume":"120","author":"Sun","year":"2024","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.biopha.2025.118439_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102474","article-title":"Mitochondrial oxidative stress contributes to diastolic dysfunction through impaired mitochondrial dynamics","volume":"57","author":"Lozhkin","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118439_bib23","doi-asserted-by":"crossref","unstructured":"Guide for the Care and Use of Laboratory Animals, National Academies Press, Washington, D.C., 2011. https:\/\/doi.org\/10.17226\/12910.","DOI":"10.17226\/12910"},{"key":"10.1016\/j.biopha.2025.118439_bib24","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.3390\/ijms22073570","article-title":"Sacubitril\/Valsartan improves diastolic function but not skeletal muscle function in a rat model of HFpEF","volume":"22","author":"Schauer","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118439_bib25","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jacbts.2021.12.009","article-title":"Clinical phenotypes of heart failure with preserved ejection fraction to select preclinical animal models","volume":"7","author":"van Ham","year":"2022","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.biopha.2025.118439_bib26","doi-asserted-by":"crossref","first-page":"H1552","DOI":"10.1152\/ajpheart.00182.2019","article-title":"A novel method optimizing the normalization of cardiac parameters in small animal models: the importance of dimensional indexing","volume":"316","author":"Hagdorn","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.118439_bib27","article-title":"Abstract 15553: the sGC stimulator vericiguat improved outcome in a rodent model of heart failure with preserved ejection fraction (HFpEF)","volume":"138","author":"Mathar","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118439_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006170","article-title":"Mitochondrial reversible changes determine diastolic function adaptations during myocardial (Reverse) remodeling","volume":"13","author":"Miranda-Silva","year":"2020","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.870699","article-title":"Liquiritin attenuates pathological cardiac hypertrophy by activating the PKA\/LKB1\/AMPK pathway","volume":"13","author":"Aiyasiding","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2025.118439_bib30","doi-asserted-by":"crossref","first-page":"H459","DOI":"10.1152\/ajpheart.00401.2018","article-title":"Early myocardial changes induced by doxorubicin in the nonfailing dilated ventricle","volume":"316","author":"Rodrigues","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.118439_bib31","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/antiox11050864","article-title":"Recent approaches to determine static and dynamic redox State-Related parameters","volume":"11","author":"Mas-Bargues","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2025.118439_bib32","doi-asserted-by":"crossref","unstructured":"C. Doerrier, L.F. Garcia-Souza, G. Krumschnabel, Y. Wohlfarter, A.T. M\u00e9sz\u00e1ros, E. Gnaiger, High-Resolution FluoRespirometry and OXPHOS Protocols for Human Cells, Permeabilized Fibers from Small Biopsies of Muscle, and Isolated Mitochondria, in: 2018: pp. 31\u201370. https:\/\/doi.org\/10.1007\/978-1-4939-7831-1_3.","DOI":"10.1007\/978-1-4939-7831-1_3"},{"key":"10.1016\/j.biopha.2025.118439_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116157","article-title":"Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue","volume":"223","author":"Arag\u00f3n-Herrera","year":"2024","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.biopha.2025.118439_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116571","article-title":"Cardiometabolic effects of sacubitril\/valsartan in a rat model of heart failure with preserved ejection fraction","volume":"230","author":"Mora\u00f1a-Fern\u00e1ndez","year":"2024","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.biopha.2025.118439_bib35","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at 20 years: 2025 update","volume":"53","author":"Perez-Riverol","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2025.118439_bib36","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/pr201223p","article-title":"Obesity-Dependent metabolic signatures associated with nonalcoholic fatty liver disease progression","volume":"11","author":"Barr","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.biopha.2025.118439_bib37","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002620RR","article-title":"Relaxin has beneficial effects on liver lipidome and metabolic enzymes","volume":"35","author":"Arag\u00f3n-Herrera","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2025.118439_bib38","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jprot.2015.01.019","article-title":"Enhancing metabolomics research through data mining","volume":"127","author":"Mart\u00ednez-Arranz","year":"2015","journal-title":"J. Proteom."},{"key":"10.1016\/j.biopha.2025.118439_bib39","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202501-0034OC","article-title":"PVDOMICS study group, metabolomic evidence of biological overlap with HFpEF in a subset of pulmonary arterial hypertension","author":"Reddy","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.biopha.2025.118439_bib40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00395-023-01018-w","article-title":"The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches","volume":"118","author":"Chen","year":"2023","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib41","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1002\/ehf2.13514","article-title":"Right ventricular and cyclic guanosine monophosphate signalling abnormalities in stages b and c of heart failure with preserved ejection fraction","volume":"8","author":"Petit","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib42","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction","volume":"81","author":"Borlaug","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41572-024-00540-y","article-title":"Heart failure with preserved ejection fraction","volume":"10","author":"Hamo","year":"2024","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.biopha.2025.118439_bib44","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","article-title":"Heart failure with preserved ejection fraction: everything the clinician needs to know","volume":"403","author":"Campbell","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118439_bib45","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/eurjpc\/zwad127","article-title":"Prognostic benefit of early diagnosis with exercise stress testing in heart failure with preserved ejection fraction","volume":"30","author":"Saito","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib46","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","article-title":"Heart failure with preserved ejection fraction in perspective","volume":"124","author":"Pfeffer","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118439_bib47","doi-asserted-by":"crossref","first-page":"46","DOI":"10.14336\/AD.2022.0523","article-title":"The NO-cGMP-PKG axis in HFpEF: from pathological mechanisms to potential therapies","volume":"14","author":"Cai","year":"2023","journal-title":"Aging Dis."},{"key":"10.1016\/j.biopha.2025.118439_bib48","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1093\/cvr\/cvac166","article-title":"Cardiac metabolism in HFpEF: from fuel to signalling","volume":"118","author":"Capone","year":"2023","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.biopha.2025.118439_bib49","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010395","article-title":"Left ventricular gene expression in heart failure with preserved ejection Fraction\u2014Profibrotic and proinflammatory pathways and genes","volume":"16","author":"Ye","year":"2023","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib50","article-title":"Pathophysiological insights into HFpEF from studies of human cardiac tissue","author":"Fayyaz","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib51","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1111\/bph.15698","article-title":"Soluble GC stimulators and activators: past, present and future","volume":"181","author":"Sandner","year":"2024","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118439_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106931","article-title":"Modulation of the nitric oxide\/cGMP pathway in cardiac contraction and relaxation: potential role in heart failure treatment","volume":"196","author":"Mollace","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.biopha.2025.118439_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13378","article-title":"Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction","volume":"228","author":"Miranda-Silva","year":"2020","journal-title":"Acta Physiol."},{"key":"10.1016\/j.biopha.2025.118439_bib54","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/ehf2.12915","article-title":"ZSF1 rat as animal model for HFpEF: development of reduced diastolic function and skeletal muscle dysfunction","volume":"7","author":"Schauer","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib55","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011107","article-title":"Empagliflozin improves diastolic function in HFpEF by restabilizing the mitochondrial respiratory chain","volume":"17","author":"Schauer","year":"2024","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead129","article-title":"Pericyte loss initiates microvascular dysfunction in the development of diastolic dysfunction","volume":"4","author":"Simmonds","year":"2023","journal-title":"Eur. Heart J. Open"},{"key":"10.1016\/j.biopha.2025.118439_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12933-024-02398-6","article-title":"Interactions between the gut microbiome, associated metabolites and the manifestation and progression of heart failure with preserved ejection fraction in ZSF1 rats","volume":"23","author":"Guivala","year":"2024","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.biopha.2025.118439_bib58","doi-asserted-by":"crossref","first-page":"F697","DOI":"10.1152\/ajprenal.00003.2020","article-title":"Praliciguat inhibits progression of diabetic nephropathy in ZSF1 rats and suppresses inflammation and apoptosis in human renal proximal tubular cells","volume":"319","author":"Liu","year":"2020","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2025.118439_bib59","doi-asserted-by":"crossref","first-page":"H523","DOI":"10.1152\/ajpheart.00386.2021","article-title":"SGLT2 inhibition potentiates the cardiovascular, renal, and metabolic effects of sGC stimulation in hypertensive rats with prolonged exposure to high-fat diet","volume":"322","author":"Reverte","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.118439_bib60","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000526934","article-title":"Responses in blood pressure and kidney function to soluble guanylyl cyclase stimulation or activation in normal and diabetic rats","volume":"147","author":"Patel","year":"2023","journal-title":"Nephron"},{"key":"10.1016\/j.biopha.2025.118439_bib61","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-019-05062-x","article-title":"An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension","volume":"63","author":"Hanrahan","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2025.118439_bib62","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1038\/ncomms8235","article-title":"Stimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissue","volume":"6","author":"Hoffmann","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118439_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121929","article-title":"Vericiguat preserved cardiac function and mitochondrial quality in a rat model of mitral regurgitation","volume":"328","author":"Jungtanasomboon","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.118439_bib64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.trsl.2024.07.005","article-title":"Vericiguat attenuates doxorubicin-induced cardiotoxicity through the PRKG1\/PINK1\/STING axis","volume":"273","author":"Zeng","year":"2024","journal-title":"Transl. Res."},{"key":"10.1016\/j.biopha.2025.118439_bib65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jchf.2017.08.013","article-title":"C.M. O\u2019Connor, A multicenter, randomized, Double-Blind, Placebo-Controlled trial of the efficacy and safety of the oral soluble guanylate cyclase stimulator","volume":"6","author":"Armstrong","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib66","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1111\/bph.15333","article-title":"Stimulation of soluble guanylyl cyclase (sGC) by riociguat attenuates heart failure and pathological cardiac remodelling","volume":"179","author":"R\u00fcdebusch","year":"2022","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118439_bib67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2016.04.098","article-title":"Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice","volume":"216","author":"Pradhan","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib68","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0183-2023","article-title":"The nitric oxide\u2013soluble guanylate cyclase\u2013cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase","volume":"33","author":"Benza","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.biopha.2025.118439_bib69","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1021\/acs.jmedchem.7b00449","article-title":"Discovery of the soluble guanylate cyclase stimulator vericiguat (BAY 1021189) for the treatment of chronic heart failure","volume":"60","author":"Follmann","year":"2017","journal-title":"J. Me.d Chem."},{"key":"10.1016\/j.biopha.2025.118439_bib70","doi-asserted-by":"crossref","DOI":"10.1253\/circj.CJ-24-0659","article-title":"Soluble guanylate cyclase stimulator vericiguat attenuates angiotensin II-Induced oxidative stress and cardiac remodeling","author":"Harada","year":"2025","journal-title":"Circ. J."},{"key":"10.1016\/j.biopha.2025.118439_bib71","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41569-022-00692-y","article-title":"The microtubule cytoskeleton in cardiac mechanics and heart failure","volume":"19","author":"Caporizzo","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib72","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-018-0046-2","article-title":"Suppression of detyrosinated microtubules improves cardiomyocyte function in human heart failure","volume":"24","author":"Chen","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2025.118439_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.837486","article-title":"Transcriptional, post-transcriptional, and post-translational mechanisms rewrite the tubulin code during cardiac hypertrophy and failure","volume":"10","author":"Phyo","year":"2022","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.118439_bib74","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cellsig.2017.06.014","article-title":"Tubulin beta 3 and 4 are involved in the generation of early fibrotic stages","volume":"38","author":"Wawro","year":"2017","journal-title":"Cell Signal"},{"key":"10.1016\/j.biopha.2025.118439_bib75","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ebiom.2018.10.017","article-title":"Microtubule associated protein 4 phosphorylation leads to pathological cardiac remodeling in mice","volume":"37","author":"Li","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2025.118439_bib76","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-021-03573-5","article-title":"MARK4 controls ischaemic heart failure through microtubule detyrosination","volume":"594","author":"Yu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118439_bib77","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0008-6363(99)00422-8","article-title":"J. Molkentin, hypertrophic defect unmasked by calcineurin expression in asymptomatic tropomodulin overexpressing transgenic mice","volume":"46","author":"Sussman","year":"2000","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.biopha.2025.118439_bib78","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.109.889725","article-title":"Molecular and functional characterization of a novel Cardiac-Specific human tropomyosin isoform","volume":"121","author":"Rajan","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118439_bib79","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.118.036259","article-title":"Mitochondrial dysfunction in heart failure with preserved ejection fraction","volume":"139","author":"Kumar","year":"2019","journal-title":"Circulation"},{"issue":"1979","key":"10.1016\/j.biopha.2025.118439_bib80","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1126\/science.1079368","article-title":"Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide","volume":"299","author":"Nisoli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.biopha.2025.118439_bib81","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/CIRCULATIONAHA.117.028723","article-title":"cGMP-Elevating compounds and ischemic conditioning provide cardioprotection against ischemia and reperfusion injury via Cardiomyocyte-Specific BK channels","volume":"136","author":"Frankenreiter","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118439_bib82","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00395-014-0421-1","article-title":"Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition","volume":"109","author":"Fraccarollo","year":"2014","journal-title":"Basic Res Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib83","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamacardio.2023.0957","article-title":"Skeletal muscle mitochondrial respiration and exercise intolerance in patients with heart failure with preserved ejection fraction","volume":"8","author":"Scandalis","year":"2023","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib84","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s44161-024-00516-x","article-title":"Myocardial ultrastructure of human heart failure with preserved ejection fraction","volume":"3","author":"Meddeb","year":"2024","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2025.118439_bib85","doi-asserted-by":"crossref","first-page":"E449","DOI":"10.1152\/ajpendo.00127.2016","article-title":"Posttranslational modifications and dysfunction of mitochondrial enzymes in human heart failure","volume":"311","author":"Sheeran","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118439_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115405","article-title":"Targeting mitochondrial impairment for the treatment of cardiovascular diseases: from hypertension to ischemia-reperfusion injury, searching for new pharmacological targets","volume":"208","author":"Todisco","year":"2023","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.biopha.2025.118439_bib87","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/cvr\/cvr051","article-title":"Metabolic fingerprint of ischaemic cardioprotection: importance of the malate-aspartate shuttle","volume":"91","author":"Nielsen","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2025.118439_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100880","article-title":"The extensive and functionally uncharacterized mitochondrial phosphoproteome","volume":"297","author":"Niemi","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118439_bib89","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cvr\/cvn161","article-title":"Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function","volume":"80","author":"Feng","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2025.118439_bib90","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.yjmcc.2020.05.008","article-title":"A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF","volume":"144","author":"Summer","year":"2020","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00395-020-0815-1","article-title":"Selective NADH communication from \u03b1-ketoglutarate dehydrogenase to mitochondrial transhydrogenase prevents reactive oxygen species formation under reducing conditions in the heart","volume":"115","author":"Wagner","year":"2020","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib92","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s12276-022-00800-5","article-title":"Cardiac-specific overexpression of Ndufs1 ameliorates cardiac dysfunction after myocardial infarction by alleviating mitochondrial dysfunction and apoptosis","volume":"54","author":"Qi","year":"2022","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.biopha.2025.118439_bib93","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/jcsm.12968","article-title":"Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility","volume":"13","author":"Adams","year":"2022","journal-title":"J. Cachex.. Sarcopenia Muscle"},{"key":"10.1016\/j.biopha.2025.118439_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116185","article-title":"Transcriptional control of cardiac energy metabolism in health and disease: lessons from animal models","volume":"224","author":"Rubio-Tom\u00e1s","year":"2024","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.biopha.2025.118439_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114809","article-title":"Pathogenic mitochondrial dysfunction and metabolic abnormalities","volume":"193","author":"Moos","year":"2021","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.biopha.2025.118439_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123755","article-title":"Mitochondrial cristae in health and disease","volume":"235","author":"Huang","year":"2023","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2025.118439_bib97","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/CIRCRESAHA.123.322654","article-title":"Mitochondrial GSNOR alleviates cardiac dysfunction via ANT1 denitrosylation","volume":"133","author":"Tang","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118439_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmg.2010.06.018","article-title":"Adenine nucleotide translocase 1 deficiency results in dilated cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and activation of apoptosis","volume":"4","author":"Narula","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.biopha.2025.118439_bib99","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.106.643296","article-title":"Accelerated mitochondrial adenosine Diphosphate\/Adenosine triphosphate transport improves Hypertension-Induced heart disease","volume":"115","author":"Walther","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118439_bib100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tem.2023.11.004","article-title":"Mitochondrial quality control pathways sense mitochondrial protein import","volume":"35","author":"Lee-Glover","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118439_bib101","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.freeradbiomed.2025.03.012","article-title":"The nuclear-mitochondrial crosstalk in aging: from mechanisms to therapeutics","volume":"232","author":"Feng","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2025.118439_bib102","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1038\/s41467-024-49611-4","article-title":"DYRK1A signalling synchronizes the mitochondrial import pathways for metabolic rewiring","volume":"15","author":"Marada","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118439_bib103","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41556-024-01555-z","article-title":"Chaperone-mediated insertion of mitochondrial import receptor TOM70 protects against diet-induced obesity","volume":"27","author":"Latorre-Muro","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118439_bib104","article-title":"TUFM in health and disease: exploring its multifaceted roles","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118439_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110524","article-title":"Phosphorylation of mammalian mitochondrial EF-Tu by fyn and c-Src kinases","volume":"101","author":"Koc","year":"2023","journal-title":"Cell Signal"},{"key":"10.1016\/j.biopha.2025.118439_bib106","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/hh1701.096038","article-title":"Phosphorylation of mitochondrial elongation factor tu in ischemic myocardium","volume":"89","author":"He","year":"2001","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2025.118439_bib107","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1152\/physrev.00041.2020","article-title":"Mitochondrial calcium exchange in physiology and disease","volume":"102","author":"Garbincius","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.118439_bib108","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCRESAHA.123.324026","article-title":"MICU3 regulates mitochondrial calcium and cardiac hypertrophy","volume":"135","author":"Roman","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118439_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2022.102618","article-title":"Altered composition of the mitochondrial Ca2+uniporter in the failing human heart","volume":"105","author":"Paillard","year":"2022","journal-title":"Cell Calcium"},{"key":"10.1016\/j.biopha.2025.118439_bib110","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.123.324103","article-title":"Blunted cardiac mitophagy in response to metabolic stress contributes to HFpEF","volume":"135","author":"Yoshii","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118439_bib111","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/cvr\/cvn280","article-title":"Mitochondrial oxidative stress and dysfunction in myocardial remodelling","volume":"81","author":"Tsutsui","year":"2008","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.biopha.2025.118439_bib112","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00395-021-00885-5","article-title":"Thiol-based redox-active proteins as cardioprotective therapeutic agents in cardiovascular diseases","volume":"116","author":"Andreadou","year":"2021","journal-title":"Basic Res Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102275","article-title":"Peroxiredoxin 3 deficiency induces cardiac hypertrophy and dysfunction by impaired mitochondrial quality control","volume":"51","author":"Sonn","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118439_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102264","article-title":"Voltage dependent anion channel 3 (VDAC3) protects mitochondria from oxidative stress","volume":"51","author":"Reina","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.118439_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadva.2023.100092","article-title":"Novel dicarbonyl metabolic pathway via mitochondrial ES1 possessing glyoxalase III activity","volume":"3","author":"Ito","year":"2023","journal-title":"BBA Adv."},{"key":"10.1016\/j.biopha.2025.118439_bib116","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3390\/antiox13080955","article-title":"Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) ameliorate heart failure through reductions in oxidative stress: a systematic review and Meta-Analysis","volume":"13","author":"Seth","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2025.118439_bib117","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/s41467-019-08921-8","article-title":"Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118439_bib118","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","article-title":"The pentose phosphate pathway in health and disease","volume":"5","author":"TeSlaa","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2025.118439_bib119","article-title":"NRF2 activation in the heart induces glucose metabolic reprogramming and reduces cardiac dysfunction via upregulation of the pentose phosphate pathway","author":"Zoccarato","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2025.118439_bib120","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/CIRCRESAHA.122.321227","article-title":"L-2-Hydroxyglutarate protects against cardiac injury via metabolic remodeling","volume":"131","author":"He","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118439_bib121","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00395-023-01018-w","article-title":"The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches","volume":"118","author":"Chen","year":"2023","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.biopha.2025.118439_bib122","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.3389","article-title":"Landscape of glycolytic metabolites and their regulating proteins in myocardium from human heart failure with preserved ejection fraction","author":"Koleini","year":"2024","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2025.118439_bib123","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.122.321050","article-title":"ATF4 protects the heart from failure by antagonizing oxidative stress","volume":"131","author":"Wang","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.118439_bib124","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1161\/CIRCULATIONAHA.124.067876","article-title":"An NRF2\/\u03b23-Adrenoreceptor axis drives a sustained antioxidant and metabolic rewiring through the Pentose-Phosphate pathway to alleviate cardiac stress","volume":"151","author":"Michel","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.118439_bib125","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/antiox13101167","article-title":"Metabolomic profiling reveals that exercise lowers biomarkers of cardiac dysfunction in rats with type 2 diabetes","volume":"13","author":"Wang","year":"2024","journal-title":"Antioxidants"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500633X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500633X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:44:10Z","timestamp":1778633050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500633X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":125,"alternative-id":["S075333222500633X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118439","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble guanylate cyclase stimulation improves cardiac function and mitochondrial activity in a rat model of early-stage heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118439"}}